Precision Peptide Co Valuation Multiples

Precision Peptide Co is valued at $15M as of September 2026. In the last fiscal year, Precision Peptide Co revenue was $36K and Precision Peptide Co EBITDA was ($3M).

Precision Peptide Co Overview

About Precision Peptide Co

Pangea Wellness Inc is a North American manufacturer specializing in clean-label foods and wellness products. Through its subsidiary, the company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.


Founded

2021

HQ

Canada

Employees

2

Financials (Last FY)

Revenue: $36K
EBITDA: ($3M)

EV

$14M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Precision Peptide Co Financials

Precision Peptide Co reported last fiscal year revenue of $36K and negative EBITDA of ($3M).

In the same fiscal year, Precision Peptide Co generated $16K in gross profit, ($3M) in EBITDA losses, and had net loss of ($3M).


Precision Peptide Co P&L

In the most recent fiscal year, Precision Peptide Co reported revenue of $36K and EBITDA of ($3M).

Precision Peptide Co is unprofitable as of last fiscal year, with gross margin of 44%, EBITDA margin of (8939%), and net margin of (9104%).

See analyst estimates for Precision Peptide Co
Last FY202620272028
Revenue$36K
Gross Profit$16K
Gross Margin44%
EBITDA($3M)
EBITDA Margin(8939%)
EBIT Margin(4530%)
Net Profit($3M)
Net Margin(9104%)
Net Debt($687K)

Financial data powered by Morningstar, Inc.

Precision Peptide Co Stock Performance

Precision Peptide Co has current market cap of $15M, and enterprise value of $14M.

Market Cap Evolution


Precision Peptide Co's stock price is $0.31.

Precision Peptide Co has an EPS (earnings per share) of $-0.07.

See more trading valuation data for Precision Peptide Co
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$14M$15M-0.0%---$-0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Precision Peptide Co Valuation Multiples

Precision Peptide Co trades at 392.9x EV/Revenue multiple, and (4.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for Precision Peptide Co

Precision Peptide Co Financial Valuation Multiples

As of September 22, 2026, Precision Peptide Co has market cap of $15M and EV of $14M.

Precision Peptide Co has a P/E ratio of (4.5x).

Last FY202620272028
EV/Revenuen/m
EV/EBITDA(4.4x)
EV/EBIT(8.7x)
EV/Gross Profitn/m
P/E(4.5x)
EV/FCF(8.4x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Precision Peptide Co Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Precision Peptide Co Margins & Growth Rates

In the most recent fiscal year, Precision Peptide Co reported gross margin of 44%, EBITDA margin of (8939%), and net margin of (9104%).

See estimated margins and future growth rates for Precision Peptide Co

Precision Peptide Co Margins

Last FY202720282029
Gross Margin44%
EBITDA Margin(8939%)
EBIT Margin(4530%)
Net Margin(9104%)
FCF Margin(4694%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Precision Peptide Co Operational KPIs

Precision Peptide Co's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.8M for the same period.

Access forward-looking KPIs for Precision Peptide Co
Last FY202620272028
Revenue per Employee$0.0M
Opex per Employee$0.8M
S&M Expenses to Revenue1178%
G&A Expenses to Revenue284%
R&D Expenses to Revenue53%
Opex to Revenue4574%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Precision Peptide Co Competitors

Precision Peptide Co competitors include KKO International, Slaturfelag Suourlands, Industrias Productos Alimenticios, Ecomiam, HYTN Innovations, Hipromine, Epsium Enterprise, Lohilo Foods, Kafelaku Coffee Holding and Vitaminka.

Most Precision Peptide Co public comparables operate across Food & Beverages.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
KKO International$20M$3M1.1x-7.3x-
Slaturfelag Suourlands$159M$16M0.1x-0.9x-
Industrias Productos Alimenticios$144M$11M----
Ecomiam$45M($3M)0.3x0.3x(4.3x)(5.1x)
HYTN Innovations$1M($823K)11.8x-(17.1x)-
Hipromine$3M($5M)19.2x-(11.2x)-
Epsium Enterprise$5M($1M)2.9x-(9.9x)-
Lohilo Foods$19M$601K0.8x-23.9x-

This data is available for Pro users. Sign up to see all Precision Peptide Co competitors and their valuation data.

Start Free Trial

Precision Peptide Co VC Funding History

Before going public, Precision Peptide Co raised $1M in total equity funding, across 1 round.


Precision Peptide Co Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Nov-21Seed-$1M--

Acquisitions by Precision Peptide Co

Precision Peptide Co has acquired 2 companies to date.

Last acquisition by Precision Peptide Co was on April 9th 2025. Precision Peptide Co acquired Amino Innovations for $2M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Precision Peptide Co

Amino Innovations
Glory Juice Co
Description
Amino Innovations is a wellness products company offering peptide-infused formulations for skin health and personal care. Based in the United States, it develops topical solutions like serums and creams harnessing short-chain peptides to promote collagen production, reduce wrinkles, and enhance hydration. Key products target anti-aging, recovery, and performance optimization through bioavailable amino acid complexes derived from natural sources. The brand emphasizes clean ingredients free from parabens and emphasizes clinical backing for efficacy in retail channels.
Glory Juice Co is a New York City-based producer of organic cold-pressed juices and plant-based wellness shots. The company sources ingredients from local farms in upstate New York and distributes through cafes, gyms, and online subscriptions in the Northeast United States. Glory Juice Co offers flavors like green juice with kale and apple alongside smoothies and tonics. It operates physical locations in Manhattan and Brooklyn emphasizing sustainability through recyclable packaging.
HQ CountryUnited StatesCanada
HQ City
Dover, DE
Vancouver
Deal Date9 Apr 202524 Apr 2023
Valuation$2M$1M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Precision Peptide Co acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Precision Peptide Co

When was Precision Peptide Co founded?Precision Peptide Co was founded in 2021.
Where is Precision Peptide Co headquartered?Precision Peptide Co is headquartered in Canada.
How many employees does Precision Peptide Co have?As of today, Precision Peptide Co has over 2 employees.
Who is the CEO of Precision Peptide Co?Precision Peptide Co's CEO is Pratap Sandhu.
Is Precision Peptide Co publicly listed?Yes, Precision Peptide Co is a public company listed on Canadian Securities Exchange.
What is the stock symbol of Precision Peptide Co?Precision Peptide Co trades under BPC ticker.
When did Precision Peptide Co go public?Precision Peptide Co went public in 2022.
Who are competitors of Precision Peptide Co?Precision Peptide Co main competitors include KKO International, Slaturfelag Suourlands, Industrias Productos Alimenticios, Ecomiam, HYTN Innovations, Hipromine, Epsium Enterprise, Lohilo Foods, Kafelaku Coffee Holding, Vitaminka.
What is the current market cap of Precision Peptide Co?Precision Peptide Co's current market cap is $15M.
What is the current revenue of Precision Peptide Co?Precision Peptide Co's last fiscal year revenue is $36K.
What is the current EV/Revenue multiple of Precision Peptide Co?Current revenue multiple of Precision Peptide Co is 392.9x.
Is Precision Peptide Co profitable?No, Precision Peptide Co is not profitable.
How many companies Precision Peptide Co has acquired to date?As of September 2026, Precision Peptide Co has acquired 2 companies.
What was the largest acquisition by Precision Peptide Co?$2M acquisition of Amino Innovations on 9th April 2025 was the largest M&A Precision Peptide Co has done to date.
What companies Precision Peptide Co acquired?Precision Peptide Co acquired Amino Innovations and Glory Juice Co.
In how many companies Precision Peptide Co has invested to date?Precision Peptide Co hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Precision Peptide Co

Lists including Precision Peptide Co

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial